Mirae Asset Global Investments Co., Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,767 shares of TVTX stock, worth $52,185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,767
Previous 2,273
21.73%
Holding current value
$52,185
Previous $18,000
111.11%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TVTX
# of Institutions
194Shares Held
84.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$144 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$130 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$88.3 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$81.9 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.21B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...